Key safety observations from available trial data include: Elevated resting heart rate in a dose-dependent manner Gastrointestinal adverse effects (nausea, vomiting, diarrhoea) as the most common side effects, consistent with the GLP-1 receptor agonist class [1] [3] No clinically significant QT interval prolongation was reported in available data, though the extent of formal thorough QT assessment has not been fully detailed in published sources
Like semaglutide and tirzepatide, it's designed for once-weekly injection, but a growing number of users are splitting their doses into smaller, more frequent injections instead
Your doctor will review your medical history, underlying medical conditions, family medical history, medications, prior methods of weight loss, and your health goals
Many people join who have tried other programmes and find that this programme delivers while also being easy to follow and with nutrient dense foods